New report for Physician Office Laboratory Testing Markets by Kalorama Information
10 Jan 2012 • by Natalie Aster
The term physician office lab (POL) is diverse. It encompasses physician practices as small as 2 to 5 doctors that perform a few rapid tests to large practices of some 200 physicians that operate labs similar to small hospital laboratories. The definition used here is therefore broad and refers to the market for tests which are: Performed in a physician office setting, at the time of a consultation between a physician or other healthcare professional (nurse practitioner, pharmacist, provides a result to be used during the medical visit and, is used for screening, diagnosis or monitoring purposes.
According to the report “Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends” by Kalorama Information, growth in physician office testing is fueled by trends in preventative medicine and proactive approaches in treating the increasing number of diagnosed diabetics; by the globalization of infectious diseases and the associated public health issues; and by the need to monitor the explosion of people with cardiovascular disease and other chronic conditions.
Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends
Published: Nov, 2010
Price: US$ 3.995,00
This exhaustive report provides:
- Discussions of the Regulatory Environment for POLs in various countries and regions
- The Top POL-conducted Tests and average reimbursement level
- POL Test Revenues by Type of Test, 2009-2014, for more than 35 test segments
- POL Test Revenues by Region (Europe, Asia, US) , 2009 to 2014
- Breakout of the Number of POLSin the US by type (CLIA-waived, non-waived)
- Regional POL market environments in top Geographic markets
- Profiles of the POL Offerings of over 75 Suppliers
- SWOT Analysis for Physician Office Testing
- Market Analyses for Key POL Testing Areas
The world market for the POL sector of point-of-care diagnostics is provided in U.S. dollars for the years 2009 - 2014. No adjustments have been made to the market data for the effects of currency exchange fluctuations or inflation. This may seem problematic, given the drastic devaluation of the U.S. dollar versus the Japanese Yen, euro and Swiss Franc. Kalorama has decided to use a constant exchange rate because it is a more accurate reflection of actual revenue growth in dollars rather than growth due to exchange rate fluctuations.
More information can be found in the report “Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and Future Trends” by Kalorama Information.
To order the report or ask for sample pages contact [email protected]